Novavax Wins $1.6B in “Warp Speed” Funding; Plans First 100M Doses of COVID-19 Vaccine
Novavax has been awarded $1.6 billion toward late-stage clinical trials and large-scale manufacturing to produce 100 million doses of its COVID-19 vaccine by year’s end through President Donald Trump’s “Operation Warp Speed” program.